Search results
Outdoor workers face skin cancer danger
Medical Xpress· 2 days agoSteve Murray, 68, has spent a lot of time out in the sun, at work and at play. Murray worked construction for several decades, and as a child spent...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 4 days agoThe duo already has promising results in patients who received a combination of the cancer vaccine...
Adlai Nortye Ltd. (NASDAQ:ANL) Short Interest Update
ETF DAILY NEWS· 22 hours agoAdlai Nortye Ltd. (NASDAQ:ANL – Get Free Report) saw a large growth in short interest in the month of April. As of April 30th, there was short interest totalling 11,500 shares, a growth of 101.8% ...
Rakuten Medical Announces Poster Presentation and Booth Exhibition at ASCO 2024 Annual Meeting
KTLA-TV Los Angeles· 3 days agoSAN DIEGO, May 9, 2024 /PRNewswire/ -- Rakuten Medical, Inc., a global biotechnology company developing and commercializing precision, cell-targeting photoimmunotherapy based ...
Outdoor Workers Face Skin Cancer Danger
KTBS Shreveport· 3 days agoSteve Murray, 68, has spent a lot of time out in the sun, at work and at play. Murray worked construction for several decades, and as a child spent...
How Is Seborrheic Dermatitis Treated?
Health via Yahoo News· 1 day agoPotential side effects of long-term use may include folliculitis, contact dermatitis (an itchy rash) on the fingers, and bruising skin. Some research...
Calliditas announces positive topline results of Phase 2 head and neck cancer trial with lead NOX...
WKRN Nashville· 7 days agoThe analysis showed statistically significant improvements in progression-free survival (PFS), as well as in overall survival (OS), with statistically significant changes in tumor biology consistent ...
Indoor tanning beds and eyelash extensions: are they safe for teenagers? | Expert Opinion
Philly.com· 16 hours agoIronically, this is also the time during normal adolescent development when they believe in the...
Wedbush Boosts Janux Therapeutics (NASDAQ:JANX) Price Target to $74.00
ETF DAILY NEWS· 2 days agoJanux Therapeutics (NASDAQ:JANX – Free Report) had its target price increased by Wedbush from $53.00 to $74.00 in a research note published on Wednesday morning, Marketbeat reports. The brokerage ...
Q1 2024 CytomX Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 4 days agoAmassed interferon is designed to locally activate the intra-tumoral immune microenvironment with potential to drive responses across multiple cancer types, including melanoma ...
